Arovella Therapeutics Ltd (ALA.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 533 | 1,219 | 426 | 7,197 | 5,786 |
| Cost of Goods | 201 | 200 | 186 | 5,541 | 5,072 |
| Gross Profit | 332 | 1,019 | 240 | 1,656 | 713 |
| Operating Expenses | 5,127 | 3,375 | 6,347 | 3,098 | 3,318 |
| Operating Income | -4,795 | -2,356 | -6,106 | -1,442 | -2,605 |
| Interest Expense | 7 | 125 | 177 | 223 | 210 |
| Other Income | -5,142 | -6,239 | -495 | -365 | -217 |
| Pre-tax Income | -9,944 | -8,720 | -6,778 | -2,030 | -3,031 |
| Income Tax | 0 | -925 | -745 | -792 | -800 |
| Net Income Continuous | -9,944 | -7,795 | -6,033 | -1,238 | -2,231 |
| Net Income Discontinuous | N/A | N/A | 574 | N/A | N/A |
| Net Income | $-9,944 | $-7,795 | $-5,459 | $-1,238 | $-2,231 |
| EPS Basic Total Ops | -0.06 | -0.07 | -0.08 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.09 | -0.02 | -0.04 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.06 | -0.07 | -0.08 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.09 | -0.02 | -0.04 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-9,365 | $-8,124 | $-6,444 | $-1,683 | $-2,699 |